Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Driver
4.2 Challenges


5. Global Adult Vaccines Market

5.1 Market
5.2 Volume (people)


6. Adult Vaccines Market & Numbers ShareAnalysis

6.1 Adult Vaccine Market Share
6.2 By Country Adult Vaccine Market Share
6.3 Adult Vaccinated Population Share


7. Disease wise – Adult Vaccines Market

7.1 Influenza
7.2 Cervical Cancer (HPV)
7.3 Zoster (Shingles)
7.4 MMR (Measles, Mumps, and Rubella Vaccine)
7.5 Pneumococcal
7.6 Meningococcal
7.7 Hepatitis
7.8 TdaP
7.9 Travel and Miscellaneous
7.10 Varicella


8. Disease wise – Numbers of Vaccinated Adults

8.1 Influenza
8.2 Cervical Cancer (HPV)
8.3 Zoster (Shingles)
8.4 MMR
8.5 Pneumococcal
8.6 Meningococcal
8.7 Hepatitis
8.8 TdaP
8.9 Varicella


9. Country – Global Adult Vaccine Market

9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Latin America

9.2.1 Mexico
9.2.2 Brazil
9.2.3 Argentina

9.3 Europe

9.3.1 United Kingdom
9.3.2 Germany
9.3.3 France
9.3.4 Russia
9.3.5 Italy
9.3.6 Spain
9.3.7 Switzerland

9.4 Asia Pacific

9.4.1 India
9.4.2 China
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea

9.5 Middle East & Africa

9.5.1 Saudi Arabia
9.5.2 UAE
9.5.3 South Africa

9.6 Rest of the World


10. Mergers and Acquisitions in the Vaccine Industry


11. Vaccines and Regulator’s Interventions

11.1 Making and Meeting Standards of Quality and Safety
11.2 Vaccine Funding


12. Porter’s Five Forces

12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Competition
12.4 Threat of New Entrants
12.5 Threat of Substitutes


13. SWOT Analysis

13.1 Strengths
13.2 Weaknesses
13.3 Opportunities
13.4 Threats


14. Key Players Analysis

14.1 GlaxoSmithKline, plc.

14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue

14.2 Astrazeneca plc

14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue

14.3 Sanofi Pasteur

14.3.1 Overview
14.3.2 Recent Development
14.3.3 Revenue

14.4 Pfizer, Inc.

14.4.1 Overview
14.4.2 Recent Development
14.4.3 Revenue

14.5 CSL Limited

14.5.1 Overview
14.5.2 Recent Development
14.5.3 Revenue



List of Figures

Figure-01: Global – Adult Vaccine Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Adult Vaccine Market (Billion US$), 2023 – 2028
Figure-03: Global – Adult Vaccine Number (Million), 2018 – 2022
Figure-04: Global – Forecast for Adult Vaccine Number (Million), 2023 – 2028
Figure-05: Disease wise – Influenza Vaccine Market (Million US$), 2018 – 2022
Figure-06: Disease wise – Forecast for Influenza Vaccine Market (Million US$), 2023 – 2028
Figure-07: Disease wise – Cervical Cancer (HPV) Vaccine Market (Million US$), 2018 – 2022
Figure-08: Disease wise – Forecast for Cervical Cancer (HPV) Vaccine Market (Million US$), 2023 – 2028
Figure-09: Disease wise – Zoster (Shingles) Vaccine Market (Million US$), 2018 – 2022
Figure-10: Disease wise – Forecast for Zoster (Shingles) Vaccine Market (Million US$), 2023 – 2028
Figure-11: Disease wise – MMR (Measles, Mumps, and Rubella Vaccine) Vaccine Market (Million US$), 2018 – 2022
Figure-12: Disease wise – Forecast for MMR (Measles, Mumps, and Rubella Vaccine) Vaccine Market (Million US$), 2023 – 2028
Figure-13: Disease wise – Pneumococcal Vaccine Market (Million US$), 2018 – 2022
Figure-14: Disease wise – Forecast for Pneumococcal Vaccine Market (Million US$), 2023 – 2028
Figure-15: Disease wise – Meningococcal Vaccine Market (Million US$), 2018 – 2022
Figure-16: Disease wise – Forecast for Meningococcal Vaccine Market (Million US$), 2023 – 2028
Figure-17: Disease wise – Hepatitis Vaccine Market (Million US$), 2018 – 2022
Figure-18: Disease wise – Forecast for Hepatitis Vaccine Market (Million US$), 2023 – 2028
Figure-19: Disease wise – TdaP Vaccine Market (Million US$), 2018 – 2022
Figure-20: Disease wise – Forecast for TdaP Vaccine Market (Million US$), 2023 – 2028
Figure-21: Disease wise – Travel and Miscellaneous Vaccine Market (Million US$), 2018 – 2022
Figure-22: Disease wise – Forecast for Travel and Miscellaneous Vaccine Market (Million US$), 2023 – 2028
Figure-23: Disease wise – Varicella Vaccine Market (Million US$), 2018 – 2022
Figure-24: Disease wise – Forecast for Varicella Vaccine Market (Million US$), 2023 – 2028
Figure-25: Disease wise – Influenza Vaccine Number (Million), 2018 – 2022
Figure-26: Disease wise – Forecast for Influenza Vaccine Number (Million), 2023 – 2028
Figure-27: Disease wise – Cervical Cancer (HPV) Vaccine Number (Million), 2018 – 2022
Figure-28: Disease wise – Forecast for Cervical Cancer (HPV) Vaccine Number (Million), 2023 – 2028
Figure-29: Disease wise – Zoster (Shingles) Vaccine Number (Million), 2018 – 2022
Figure-30: Disease wise – Forecast for Zoster (Shingles) Vaccine Number (Million), 2023 – 2028
Figure-31: Disease wise – MMR Vaccine Number (Million), 2018 – 2022
Figure-32: Disease wise – Forecast for MMR Vaccine Number (Million), 2023 – 2028
Figure-33: Disease wise – Pneumococcal Vaccine Number (Million), 2018 – 2022
Figure-34: Disease wise – Forecast for Pneumococcal Vaccine Number (Million), 2023 – 2028
Figure-35: Disease wise – Meningococcal Vaccine Number (Million), 2018 – 2022
Figure-36: Disease wise – Forecast for Meningococcal Vaccine Number (Million), 2023 – 2028
Figure-37: Disease wise – Hepatitis Vaccine Number (Million), 2018 – 2022
Figure-38: Disease wise – Forecast for Hepatitis Vaccine Number (Million), 2023 – 2028
Figure-39: Disease wise – TdaP Vaccine Number (Million), 2018 – 2022
Figure-40: Disease wise – Forecast for TdaP Vaccine Number (Million), 2023 – 2028
Figure-41: Disease wise – Varicella Vaccine Number (Million), 2018 – 2022
Figure-42: Disease wise – Forecast for Varicella Vaccine Number (Million), 2023 – 2028
Figure-43: United States – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-44: United States – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-45: Canada – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-46: Canada – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-47: Mexico – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-48: Mexico – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-49: Brazil – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-50: Brazil – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-51: Argentina – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-52: Argentina – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-53: United Kingdom – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-54: United Kingdom – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-55: Germany – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-56: Germany – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-57: France – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-58: France – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-59: Russia – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-60: Russia – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-61: Italy – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-62: Italy – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-63: Spain – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-64: Spain – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-65: Switzerland – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-66: Switzerland – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-67: India – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-68: India – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-69: China – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-70: China – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-71: Japan – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-72: Japan – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-73: Australia – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-74: Australia – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-75: South Korea – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-76: South Korea – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-77: Saudi Arabia – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-78: Saudi Arabia – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-79: UAE – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-80: UAE – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-81: South Africa – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-82: South Africa – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-83: Rest of the World – Adult Vaccine Market (Million US$), 2018 – 2022
Figure-84: Rest of the World – Forecast for Adult Vaccine Market (Million US$), 2023 – 2028
Figure-85: GlaxoSmithKline, plc.?s Vaccines Sales – Global Revenue Market (Million US$), 2018 – 2022
Figure-86: GlaxoSmithKline, plc.?s Vaccines Sales – Forecast for Global Revenue Market (Million US$), 2023 – 2028
Figure-87: Astrazeneca plc Vaccines Sales – Global Revenue Market (Million US$), 2018 – 2022
Figure-88: Astrazeneca plc Vaccines Sales – Forecast for Global Revenue Market (Million US$), 2023 – 2028
Figure-89: Sanofi Pasteur?s Vaccines Sales – Global Revenue Market (Million US$), 2018 – 2022
Figure-90: Sanofi Pasteur?s Vaccines Sales – Forecast for Global Revenue Market (Million US$), 2023 – 2028
Figure-91: Pfizer, Inc.?s Vaccines Sales – Global Revenue Market (Million US$), 2018 – 2022
Figure-92: Pfizer, Inc.?s Vaccines Sales – Forecast for Global Revenue Market (Million US$), 2023 – 2028
Figure-93: CSL Limited sales – Global Revenue Market (Million US$), 2018 – 2022
Figure-94: CSL Limited sales – Forecast for Global Revenue Market (Million US$), 2023 – 2028

List of Tables

Table-01: Global – Adult Vaccine Market Share by Vaccine Type (Percent), 2018 – 2022
Table-02: Global – Forecast for Adult Vaccine Market Share by Vaccine Type (Percent), 2023 – 2028
Table-03: Global – Adult Vaccine Market Share by Country (Percent), 2018 – 2022
Table-04: Global – Forecast for Adult Vaccine Market Share by Country (Percent), 2023 – 2028
Table-05: Global – Adult Vaccine Population Share by Vaccine Type (Percent), 2018 – 2022
Table-06: Global – Forecast for Adult Vaccine Population Share by Vaccine Type (Percent), 2023 – 2028